ArticleBlood advances2026
Neutrophil cathepsin G potentiates biased signaling through protease-activated receptor 4.
Article in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- G protein-coupled receptor-mediated platelet thrombus formation.Current opinion in hematology · 2026Review
- Cystatin B Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting the JAK2/STAT3 Signaling Pathway.CNS neuroscience & therapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
abstractPlatelets and neutrophils play a complex role in inflammation and thrombosis. Platelets are crucial for hemostasis, forming platelet plugs at the site of vascular injury. They are also drivers of venous thromboembolism, and they participate in immune responses by interacting with neutrophils. Neutrophil recruitment to platelet plugs is integral to resolve vascular injury, but excessive neutrophil infiltration can shift the response from hemostatic to thrombotic. The neutrophil protease cathepsin G (CatG) cleaves protease-activated receptor 4 (PAR4) at alternative sites to those cleaved by thrombin, but the signaling and physiological outcomes of this interaction are understudied. Considering the interaction between platelets and neutrophils, CatG may provide a mechanism for context-specific signaling through PAR4. We used light transmission aggregometry and flow cytometry to measure platelet aggregation, integrin activation, and P-selectin surface expression on human platelets in response to CatG or the RALLLGWVPTR (RALL 11-mer), which mimics PAR4 cleavage by CatG at Ser67. We observed calcium mobilization, RhoA activation, and protein kinase B (Akt) phosphorylation in platelets to investigate which PAR4 signaling pathways are activated by CatG. Here, we show that CatG cleaves PAR4 expressed on the surface of cells at a different site than thrombin. Both CatG and the RALL 11-mer increase platelet aggregation, integrin activation, and P-selectin surface expression. Additionally, CatG activation of PAR4 increases calcium mobilization and Akt phosphorylation in platelets. The RALL 11-mer increases Akt phosphorylation to activate platelets. These results indicate that CatG uses Gαq and β-arrestin pathways to facilitate platelet aggregation in the absence of Gα12/13 signaling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.